Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis sells blood transfusion test unit to Grifols for $1.7 billion
Yahoo/Reuters
Monday, November 11, 2013 - 10:21am
tags:
Novartis, M&A, blood transfusions, Grifols
Can Orexigen Therapeutics Catch Up With Arena Pharmaceuticals and VIVUS?
Motley Fool
Monday, November 11, 2013 - 10:19am
tags:
Arena Pharmaceuticals, Vivus, obesity, Orexigen, Contrave, Belviq, Qsymia
Will Dendreon Catch Johnson & Johnson or Fall Behind Celldex?
Motley Fool
Monday, November 11, 2013 - 10:17am
tags:
Dendreon, JNJ, Celldex
Shire Buys ViroPharma for $4.2 Billion to Add Orphan Drug
Bloomberg
Monday, November 11, 2013 - 10:16am
tags:
ViroPharma, Shire, M&A
Will Biosimilars Unlock This Company's Long-Term Potential?
Daily Finance
Sunday, November 10, 2013 - 1:51pm
tags:
biosimilars, generics, Hospira
Pfizer And Merck Continue To Battle Declining Revenue
Seeking Alpha
Sunday, November 10, 2013 - 1:26pm
tags:
Pfizer, Merck
Is This Cubist's Biggest Opportunity?
Motley Fool
Sunday, November 10, 2013 - 1:22pm
tags:
Cubist Pharmaceuticals, antibiotics, antibiotic resistance
ModernGraham Valuation Of Johnson & Johnson
Seeking Alpha
Sunday, November 10, 2013 - 1:19pm
tags:
JNJ
Will Merck Be Able To Reward Its Shareholders?
Seeking Alpha
Sunday, November 10, 2013 - 1:17pm
tags:
Merck
Merck’s Investigational Grass Sublingual Allergy Immunotherapy Tablet Significantly Reduced Allergy Symptoms and Need for Symptom-Relief Medication in Adults and Children in Pivotal Phase III Study
Yahoo/BusinessWire
Sunday, November 10, 2013 - 1:13pm
tags:
Merck, immunotherapy, MK-7243, allergies
Can Arena's Obesity Handoff Create a Touchdown?
Motley Fool
Sunday, November 10, 2013 - 1:10pm
tags:
Arena Pharmaceuticals, Eisai, obesity, weight loss, Belviq
Alnylam Reports Positive Phase II Data for Patisiran (ALN-TTR02), an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of TTR-Mediated Amyloidosis (ATTR), and Initiates Phase III Trial
Yahoo/BusinessWire
Sunday, November 10, 2013 - 1:08pm
tags:
Alnylam, Patisiran, amyloidosis, TTR-mediated amyloidosis
Will the New Arthritis Drug Help Celgene Surge Higher?
Wall St Cheat Sheet
Sunday, November 10, 2013 - 12:57pm
tags:
Celgene Corporation, arthritis, apremilast, psoriatic arthritis
This Week in Biotech
Motley Fool
Sunday, November 10, 2013 - 12:56pm
tags:
Keryx, Geron, Arena, Eisai, Vivus, Curis, Immunogen
FDA to speed safety info on generic drugs
The Hill
Saturday, November 9, 2013 - 12:47pm
tags:
FDA
What Will The Probe Into The Brilinta Trial Mean For AstraZeneca?
Forbes
Saturday, November 9, 2013 - 12:44pm
tags:
legal, Brilinta, blood thinners, AstraZeneca
Despite Settlement, J&J Dividend Going Strong
investors.com
Saturday, November 9, 2013 - 12:43pm
tags:
JNJ
Multiple Reasons To Buy Incyte
Seeking Alpha
Saturday, November 9, 2013 - 12:42pm
tags:
Incyte
SAC, Prosecutors Oppose Wyeth-Elan Investor Request
Bloomberg
Saturday, November 9, 2013 - 12:41pm
tags:
Elan, legal
Make A Suave Move, Buy Novartis
Seeking Alpha
Saturday, November 9, 2013 - 12:40pm
tags:
Novartis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.